P2X7R antagonists and their use
US8815892B2 · kind B2 · utility
0Cited by
4References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 24, 2012 |
| Grant date | Aug 26, 2014 |
| Priority date | — |
| Expiry date | Jul 24, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application is directed to novel P2X7R antagonists that are indol-3-carboxamide or azaindole-3-carboxamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.